XENE CIK: 1582313

Xenon Pharmaceuticals Inc.

  • Canada
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−69.5
FY22:
−101
FY23:
−151
FY24:
−181
FY25:
−279
Change from FY21 to FY25
millions USD
FY21:
−247
FY22:
−293
FY23:
−111
FY24:
165
FY25:
218
Change from FY21 to FY25
millions USD
FY21:
448
FY22:
278
FY23:
354
FY24:
12.1
FY25:
117
millions USD
FY21:
131
FY22:
−118
FY23:
91.4
FY24:
−5.93
FY25:
56.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−71.6
FY22:
−104
FY23:
−157
FY24:
−184
FY25:
−280

All amounts in millions USD Data source:SEC EDGAR